Morning Briefing
Summaries of health policy coverage from major news organizations
Trump Official: A COVID Vaccine In January
AP: Trump Official Says Vaccine Expected Starting In January
A Trump administration official leading the response to the coronavirus pandemic says the U.S. can expect delivery of a vaccine starting in January 2021, despite statements from the president that inoculations could begin this month. And a growing, bipartisan chorus of lawmakers, experts and public health officials says the country is ill prepared for a projected winter surge of COVID-19. (Mendoza and Linderman, 10/9)
NPR: Operation Warp Speed COVID-19 Vaccine Contract Terms Unknown
Members of Congress, advocacy groups and a former administration official say Operation Warp Speed should release its vaccine contracts with pharmaceutical companies, following an NPR report that the Trump administration awarded billions of dollars through a third party, bypassing the usual contracting process. "The administration really just seems to be playing a game of hide and seek," Rep. Lloyd Doggett, D-Texas, told NPR. (Lupkin, 10/10)
Also —
The Wall Street Journal: People Harmed By Coronavirus Vaccines Will Have Little Recourse
The U.S. government paid out $4.4 billion over more than 30 years covering injuries relating to a host of vaccines—from flu to polio—but payouts for potential injuries from Covid-19 vaccines will be covered by a far less-generous program. Covid-19 vaccine injuries will be covered under a program known as the “countermeasures injury” compensation fund, which was set up in 2010 to cover harm resulting from vaccines for a flu pandemic, or drugs to treat an anthrax or Ebola outbreak, for example. (Loftus and Pulliam, 10/11)
Reuters: As Globe Gallops Into Vaccine Trials, Insurers Remain Unfazed
The world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour. Yet, while more than 40 experimental COVID-19 vaccines are being tested on humans, the insurance companies with decades of experience in assessing the risks of clinical trials don’t see anything to be unduly concerned about. Executives at insurer Allianz and brokers Gallagher and Marsh, among the leading players in clinical trials insurance, told Reuters that premiums had only marginally increased so far in the current pandemic. (Hussain, Cohn and Burger, 10/12)
Stat: Letter Urging Covid-19 Vaccine Trial Participation Sparks Backlash
The presidents of two historically Black universities in New Orleans thought they were doing a public service by enrolling in a Covid-19 vaccine clinical trial back in August, so much so they urged their campus communities to consider doing the same. “I said we should inform our communities because I think there’s something about teaching by example,” said Reynold Verret, a biochemist who leads Xavier University of Louisiana. “We’re two Black men who rolled up their sleeves.” (St. Fleur, 10/12)
